Barrans Russell

Avg. Two Year Performance

8% Avg. Purchase Return
4% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return34%14%14%32%8%
Purchase Success Rate3 of 42 of 42 of 42 of 41 of 4
Average Sale Return36%24%52%0%0%
Sale Success Rate2 of 22 of 22 of 20 of 20 of 2

Evofem Biosciences, Inc.

Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 448.83K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--